AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sekiguchi, J.-i.
Right arrow Articles by Kirikae, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sekiguchi, J.-i.
Right arrow Articles by Kirikae, T.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, September 2005, p. 3948-3951, Vol. 49, No. 9
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.9.3948-3951.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Cloning and Characterization of a Novel Trimethoprim-Resistant Dihydrofolate Reductase from a Nosocomial Isolate of Staphylococcus aureus CM.S2 (IMCJ1454)

Jun-ichiro Sekiguchi,1 Prasit Tharavichitkul,3 Tohru Miyoshi-Akiyama,1 Vena Chupia,3 Tomoko Fujino,1 Minako Araake,1 Atsushi Irie,1 Koji Morita,4 Tadatoshi Kuratsuji,2,5 and Teruo Kirikae1*

Department of Infectious Diseases,1 Research Institute, International Medical Center of Japan, Shinjuku, Tokyo 162-8655, Japan,2 Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand,3 Department of Microbiology, Kyorin University School of Health Sciences, Hachioji, Tokyo 192-8508, Japan,4 National Research Institute for Child Health and Development, Setagaya, Tokyo 157-8535, Japan5

Received 16 March 2005/ Returned for modification 24 April 2005/ Accepted 14 June 2005

A novel gene, dfrG, encoding a trimethoprim (TMP)-resistant dihydrofolate reductase (DHFR, designated S3DHFR) was cloned from a clinical isolate of methicillin-resistant Staphylococcus aureus. Escherichia coli expressing dfrG was highly resistant to TMP. Recombinant S3DHFR exhibited DHFR activity that was not inhibited by TMP.

* Corresponding author. Mailing address: Department of Infectious Diseases, Research Institute, International Medical Center of Japan, 1-21-1 Toyama, Shinjuku, Tokyo 162-8655, Japan. Phone: (81) 3 3202 7181, ext. 2838. Fax: (81) 3 3202 7364. E-mail: tkirikae{at}ri.imcj.go.jp.

Antimicrobial Agents and Chemotherapy, September 2005, p. 3948-3951, Vol. 49, No. 9
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.9.3948-3951.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.





Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2005 by the American Society for Microbiology. All rights reserved.